How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?

Sorry, there's nothing here.

Topics

Cite this paper

@article{Harputluolu2008HowCW, title={How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?}, author={Hakan Harputluoğlu and Kadri Altundag}, journal={Annals of oncology : official journal of the European Society for Medical Oncology}, year={2008}, volume={19 6}, pages={1203} }